LANXESS successfully places EUR 500 million benchmark bond


The specialty chemicals company LANXESS has successfully placed a 6-year-tenor euro benchmark bond with a coupon of 0.0 percent in the European capital market. LANXESS will use the funds to finance the planned acquisition of the microbial control business of US-based chemical company IFF.

The new bond is listed on the Luxembourg Stock Exchange in denominations of EUR 1,000.

“We have secured a first step of financing already quickly after the announcement of the acquisition of IFF Microbial Control and are happy about the very receptive reaction of the capital market to our offering,” said LANXESS Chief Financial Officer Michael Pontzen.

LANXESS' issuer ratings are currently Baa2 (Moody’s), BBB (Standard & Poor’s) and BBB+ (Scope). A bank consortium of active joint bookrunners comprising Citi, Société Générale and Unicredit was mandated to place the bond.

Information for editors:
All LANXESS news releases and their accompanying photos can be found at
Recent photos of the Board of Management and other LANXESS image material are available at

You can find further information concerning LANXESS chemistry in our digital magazine “Inside LANXESS” at



Lubricant runs over roller bearings

LANXESS expands production capacities in Asia

October 18, 2021

bp and LANXESS join forces on renewable raw materials for plastics production

October 13, 2021
Plant growing on LANXESS Scopeblue Durethan granules

LANXESS launches sustainable high-performance plastic

October 13, 2021
Tepex with natuaral fibers

New sustainable plastics for the circular economy

October 13, 2021
Terminal blocks to which cables are connected in power distribution boards or control cabinets, Durethan B30SFN31

Designed for short cycle times

October 11, 2021
Usage of Cookies
We would like to use cookies to better understand you use of this website. This enables us to improve your future experience on our website. Detailed information about the use of cookies on this website and how you can manage or withdraw your consent at any time can be found in our Privacy Statement.

OK Other Settings